As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and ...

After facing an unexpected regulatory delay last month, KalVista Pharmaceuticals has leapt into the commercial realm with the ...

German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest ...

With several high-profile drugmakers already lining up for manufacturing space, Fujifilm Biotechnologies is on the cusp of ...

Eight years after it was established partly by AstraZeneca, Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy (sunvozertinib) to become the only ...

It took several bids and months of back-and-forth negotiations, but CDMO Future Pak finally secured its long-sought buyout of HIV-focused drugmaler Theratechnologies.  | Future Pak's most recent bid ...

After several PD-1xVEGF competitors forged alliances with Big Pharma players, Summit Therapeutics, the frontrunner in this hot cancer drug field, is reportedly seeking its own deal. | After several PD ...

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...

The FDA’s regular communications based on reports from its drug safety report database don’t always rattle investors’ cages.

Boehringer Ingelheim has breathed life into an American Lung Association campaign, providing support for a new push to ...

Just days after President Donald Trump was elected in November, AstraZeneca unvei | AstraZeneca CEO Pascal Soriot is plotting ...

After taking aim at the United States’ vaccine safety reporting system earlier this year, Robert F. Kennedy Jr. | After ...